Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison
- PMID: 22009042
- DOI: 10.1097/MCA.0b013e32834d335e
Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison
Abstract
Background: Transcatheter aortic valve implantation (TAVI) has become a therapeutic alternative to surgery for the treatment of severe aortic stenosis in high-surgical risk patients. The aim of this study was to compare 30-day mortality of high-risk patients treated by TAVI versus surgical aortic valve replacement.
Methods: A total of 175 patients (60 men; mean age, 80±6 years; Euroscore 21±13%) having undergone TAVI were compared with 175 matched patients (76 men; mean age, 79±3 years; Euroscore 17±9%), which have undergone conventional aortic valve replacement and were deemed to be high-risk patients by the cardiothoracic surgeons. Thirty-day mortality and major adverse events were recorded in both groups. Patients' characteristics were analyzed for predictors of mortality in the TAVI group.
Results: Twenty-one patients (12%) in the TAVI group and 13 patients (8%) in the surgical group died within 30 days of the procedure (P=0.165). Two patients (1%) in the TAVI group and one patient (0.5%) in the conventional surgery group had a major stroke (P=1.0). Seven patients (4%) in the TAVI group and 25 patients (14%) in the conventional surgery group required dialysis post procedure (P=0.0013). The average length of stay in the intensive care unit was lower in the TAVI group compared with the conventional surgical group (3.3±3.1 vs. 6.6±10.5 days; P<0.001). Age was the only independent predictor of mortality in the TAVI group (odds ratio=1.009; 95% confidence interval: 1.001-1.018 per additional year; P=0.0186) and in the total study population (odds ratio=1.007; 95% confidence interval: 1.001-1.013 per additional year; P=0.0186).
Conclusion: In high-surgical risk patients, TAVI can be performed at a mortality risk comparable with conventional surgery with a reduced length of post interventional intensive care unit stay and less need for dialysis.
© 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Similar articles
-
Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: a comparative analysis between different risk strata.Catheter Cardiovasc Interv. 2012 Jan 1;79(1):132-40. doi: 10.1002/ccd.23100. Epub 2011 Dec 8. Catheter Cardiovasc Interv. 2012. PMID: 21538786
-
Transcatheter vs. surgical aortic valve replacement: a retrospective analysis assessing clinical effectiveness and safety.J Cardiovasc Med (Hagerstown). 2012 Apr;13(4):229-41. doi: 10.2459/JCM.0b013e3283515c0f. J Cardiovasc Med (Hagerstown). 2012. PMID: 22367569
-
Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: a propensity-matched analysis of 2 strategies in high-risk patients.J Thorac Cardiovasc Surg. 2014 Feb;147(2):561-7. doi: 10.1016/j.jtcvs.2013.10.025. Epub 2013 Nov 23. J Thorac Cardiovasc Surg. 2014. PMID: 24280712
-
Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients.EuroIntervention. 2012 May 15;8(1):129-38. doi: 10.4244/EIJV8I1A20. EuroIntervention. 2012. PMID: 22391581 Review.
-
Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients.Catheter Cardiovasc Interv. 2012 Jul 1;80(1):128-38. doi: 10.1002/ccd.23368. Epub 2012 Mar 13. Catheter Cardiovasc Interv. 2012. PMID: 22415849 Review.
Cited by
-
Efficacy of transcatheter aortic valve implantation in patients with aortic stenosis and reduced LVEF. A systematic review.Herz. 2015 Apr;40 Suppl 2:168-80. doi: 10.1007/s00059-014-4193-z. Epub 2015 Feb 26. Herz. 2015. PMID: 25712464
-
Meta-Analysis Comparing the Frequency of Stroke After Transcatheter Versus Surgical Aortic Valve Replacement.Am J Cardiol. 2018 Oct 1;122(7):1215-1221. doi: 10.1016/j.amjcard.2018.06.032. Epub 2018 Jul 5. Am J Cardiol. 2018. PMID: 30089530 Free PMC article.
-
Transcatheter Aortic Valve Replacement Is Associated with Less Oxidative Stress and Faster Recovery of Antioxidant Capacity than Surgical Aortic Valve Replacement.J Clin Med. 2019 Sep 2;8(9):1364. doi: 10.3390/jcm8091364. J Clin Med. 2019. PMID: 31480644 Free PMC article.
-
Meta-Analysis Comparing Renal Outcomes after Transcatheter versus Surgical Aortic Valve Replacement.J Interv Cardiol. 2019 Apr 24;2019:3537256. doi: 10.1155/2019/3537256. eCollection 2019. J Interv Cardiol. 2019. PMID: 31772526 Free PMC article.
-
Transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis of randomised and non-randomised trials.Open Heart. 2014 Aug 12;1(1):e000013. doi: 10.1136/openhrt-2013-000013. eCollection 2014. Open Heart. 2014. PMID: 25332780 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources